5-BROMO-7-FLUORO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95%, 1g

(E)-4,4,5,5-tetramethyl-2-(2-(trifluoromethyl)styryl)-1,3,2-dioxaborolane, 97%, 1g

4-Formyl-3-methoxybenzonitrile, 95.0%, 10g

2,3-Dihydro-1H-quinolin-4-one hydrochloride, 95.0%, 5g

Methyl (R)-4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-3-((ethoxycarbonyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 250mg

1-BENZENESULFONYL-1H-INDOLE-5-CARBONITRILE, 95.0%, 5g

1-(4-Fluoro-benzyl)-4-hydroxymethyl-pyrrolidin-2-one, 95.0%, 500mg

tert-Butyl 2-oxo-7-azaspiro[4.5]decane-7-carboxylate, 98%, 500mg

4-(4H-1,2,4-Triazol-4-yl)piperidine, 95.0%, 250mg

Ethyl 2,2-difluoro-2-(3-fluorophenyl)acetate, 95.0%, 5g

Alcohol bencílico, mínimo 98%, para síntesis, 2,5 L, envase de vidrio

2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid, 25mg

1-[4-(Trifluoromethyl)phenyl]-1H-imidazole-5-carboxylic acid, 1g